• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期大剂量服用双膦酸盐不会导致骨骼过度矿化。

[Long-term and high-dose bisphosphonate administration causes no bone over-mineralization].

作者信息

Liu Chao, Cao Yong-ping, Yang Xin, Mashiba Tasuku, Mori Satoshi

机构信息

Department of Orthopedics, Peking University First Hospital, Beijing, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2009 Nov 17;89(42):2968-71.

PMID:20137705
Abstract

OBJECTIVE

To evaluate the effects of long-term bisphosphonate administration (incadronate) upon the mean degree of secondary bone mineralization.

METHODS

Thirty adult beagles were divided randomly into three groups of CNT, YML and YMH based upon their body weights (5 males and 5 females in each group). Animals in CNT were orally given lactose 12 mg x kg(-1) x d(-1) while those in YML and YMH were orally given incadronate disodium at doses of 0.3 mg x kg(-1) x d(-1) and 0.6 mg x kg(-1) x d(-1) respectively. The dosing procedure lasted for three years. Prior to sacrifices, all animals were double-labeled intravenously with oxytetracycline hydrochloride (20 mg x kg(-1)). After necropsy, the left 9th ribs were excised for evaluation.

RESULTS

Histomorphometry showed that activation frequency in YML and YMH [(4.93 +/- 0.92)/mm(2) and (2.50 +/- 0.78)/mm(2)] were significantly lower than that in CNT (7.83 +/- 0.96)/mm(2) per year. The mean degree of mineralization in bone in YML and YMH (1.40 +/- 0.12, 1.48 +/- 0.09) were significantly higher than CNT (1.07 +/- 0.06). The increments were 31% and 38% respectively.

CONCLUSION

Long-term and high-dose bisphosphonate administration significantly suppresses bone turnover so as to increase the degree of bone mineralization. But there is no resulting bone over-mineralization. (incadronate) administration on the mean degree of secondary mineralization in bone.

摘要

目的

评估长期给予双膦酸盐(因卡膦酸)对继发性骨矿化平均程度的影响。

方法

30只成年比格犬根据体重随机分为三组,即CNT组、YML组和YMH组(每组5只雄性和5只雌性)。CNT组动物口服乳糖12 mg·kg⁻¹·d⁻¹,而YML组和YMH组动物分别口服因卡膦酸二钠,剂量为0.3 mg·kg⁻¹·d⁻¹和0.6 mg·kg⁻¹·d⁻¹。给药过程持续三年。在处死前,所有动物静脉注射盐酸土霉素(20 mg·kg⁻¹)进行双重标记。尸检后,切除左第9肋进行评估。

结果

组织形态计量学显示,YML组和YMH组的激活频率[(4.93±0.92)/mm²和(2.50±0.78)/mm²]每年显著低于CNT组[(7.83±0.96)/mm²]。YML组和YMH组骨矿化平均程度(1.40±0.12,1.48±0.09)显著高于CNT组(1.07±0.06)。增幅分别为31%和38%。

结论

长期大剂量给予双膦酸盐可显著抑制骨转换,从而提高骨矿化程度。但不会导致骨矿化过度。(因卡膦酸)给药对骨继发性矿化平均程度的影响。

相似文献

1
[Long-term and high-dose bisphosphonate administration causes no bone over-mineralization].长期大剂量服用双膦酸盐不会导致骨骼过度矿化。
Zhonghua Yi Xue Za Zhi. 2009 Nov 17;89(42):2968-71.
2
Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.长期双膦酸盐治疗抑制骨转换会累积微损伤,但能维持犬肋骨皮质骨的内在材料特性。
J Bone Miner Res. 2004 Jun;19(6):999-1005. doi: 10.1359/JBMR.040126. Epub 2004 Jan 19.
3
Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra.因卡膦酸二钠的长期治疗会累积微损伤,但可改善犬椎骨的小梁骨微结构。
J Bone Miner Res. 2003 Mar;18(3):512-20. doi: 10.1359/jbmr.2003.18.3.512.
4
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.用临床治疗剂量的利塞膦酸盐或阿仑膦酸盐治疗1年后犬椎骨骨转换、微损伤积累及生物力学特性的改变
Bone. 2006 Oct;39(4):872-9. doi: 10.1016/j.bone.2006.04.028. Epub 2006 Jun 12.
5
Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women.利塞膦酸盐3年和5年治疗对绝经后妇女髂嵴三联活检骨矿化密度分布的影响。
J Bone Miner Res. 2006 Jul;21(7):1106-12. doi: 10.1359/jbmr.060401.
6
Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.在犬类中,使用因卡膦酸盐进行3年治疗后,胶原蛋白成熟度、糖基化诱导的戊糖苷和矿化作用均增强。
Osteoporos Int. 2008 Sep;19(9):1343-54. doi: 10.1007/s00198-008-0585-3. Epub 2008 Mar 29.
7
NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).F344/N大鼠和B6C3F1小鼠经口给予邻苄基对氯苯酚(CAS编号:120-32-1)的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1994 Jan;424:1-304.
8
[Bisphosphonate therapy for osteoporosis and bone strength].[双膦酸盐治疗骨质疏松症与骨强度]
Clin Calcium. 2006 Sep;16(9):1513-19.
9
Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.双膦酸盐治疗通过微观结构而非基质特性影响小梁骨表观模量。
J Orthop Res. 2004 May;22(3):465-71. doi: 10.1016/j.orthres.2003.05.001.
10
Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography.长期使用利塞膦酸盐治疗可使骨矿化正常化,并持续保持小梁结构:采用微型计算机断层扫描的系列三重活检研究
Bone. 2006 Aug;39(2):345-52. doi: 10.1016/j.bone.2006.01.161. Epub 2006 Mar 29.

引用本文的文献

1
Identifying KLF14 as a potential regulatory factor in liver regeneration trough transcriptomic and metabolomic.通过转录组学和代谢组学确定KLF14作为肝再生中的潜在调控因子。
Sci Rep. 2025 Mar 3;15(1):7462. doi: 10.1038/s41598-025-87614-3.